Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$118.5 - $160.53 $3.35 Million - $4.54 Million
28,300 Added 1886.67%
29,800 $3.62 Million
Q1 2023

Jun 13, 2024

BUY
$135.66 - $197.02 $203,490 - $295,530
1,500 New
1,500 $230,000
Q4 2022

Feb 01, 2023

BUY
$118.38 - $210.04 $177,570 - $315,060
1,500 New
1,500 $269,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $57.1 Million - $86.1 Million
-487,800 Reduced 98.07%
9,600 $1.4 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $54.9 Million - $102 Million
433,900 Added 683.31%
497,400 $90 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $14.1 Million - $30.8 Million
63,500 New
63,500 $24.7 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.